PeptiVir, Inc.

PeptiVir owns a platform technology for the creation of new vaccines against influenza (universal), RSV, parainfluenza, SARS, HIV and Ebola viruses.

  • Stage Not Set
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Employees 0
  • Website peptivir.com

Company Summary

Team

  • Robert Hodges, Ph.D.
    VP-Chemistry

  • Kathryn Holmes, Ph.D
    VP-Virology

  • Richard Duke, Ph.D.
    Acting CEO

  • Kevin Smith
    Acting CFO

  • Robert Hodges

Advisors

  • Faegre and Benson (Corp); Morrison and Foerster (IP)
    Lawyer
    Unconfirmed
    Mullins + Assoc
    Accountant
    Unconfirmed

Previous Investors

  • Colorado Institute for Drug, Device and Diagnostic Development ($300K)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free